Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    11914243 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Exploratory Study of Plaque Regression
Condition: Heterozygous Familial Hypercholesterolemia
Intervention: Drug: CER-001
2 Completed Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
Condition: Acute Coronary Syndrome
Interventions: Drug: Placebo;   Drug: CER-001
3 Active, not recruiting Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Drug: CER-001

Indicates status has not been verified in more than two years